Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics
Launched by GENERAL HOSPITAL OF NINGXIA MEDICAL UNIVERSITY · Nov 28, 2023
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different blood pressure targets during a cesarean section affect mothers' health after the surgery. Specifically, it looks at whether maintaining higher or standard blood pressure levels helps improve how mothers feel and recover after spinal anesthesia, which is often used during cesarean deliveries.
Women between the ages of 18 and 45 who are pregnant with a single baby and scheduled for a cesarean section may be eligible to participate. To join, participants should be in good health and not have certain medical conditions, like high blood pressure or low hemoglobin levels. If you decide to participate, you can expect close monitoring during and after the procedure to see how your body responds to the different blood pressure strategies. This trial aims to ensure mothers have better outcomes after surgery, and your involvement could help improve care for others in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18-45 years
- • Primipara or multipara
- • Singleton pregnancy ≥37 weeks
- • American Society of Anesthesiologists physical status classification I to II
- • Scheduled for cesarean section under spinal anesthesia
- Exclusion Criteria:
- • Body height \< 150 cm
- • Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
- • Eclampsia or chronic hypertension or baseline blood pressure ≥180 mmHg
- • Hemoglobin \< 7g/dl
- • Fetal distress, or known fetal developmental anomaly
About General Hospital Of Ningxia Medical University
The General Hospital of Ningxia Medical University is a leading healthcare institution dedicated to advancing medical research and patient care. As a prominent clinical trial sponsor, the hospital integrates cutting-edge research with its extensive clinical expertise to facilitate innovative studies across various medical fields. With a commitment to improving health outcomes, the General Hospital of Ningxia Medical University collaborates with researchers and healthcare professionals to conduct rigorous trials that adhere to the highest ethical and scientific standards, ultimately contributing to the advancement of medical knowledge and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Xinli Ni, Ph.D
Study Chair
General Hospital of Ningxia Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported